MELANOMA [NEW TOPIC PAGE]

Main|Search|PHGKB



From PubMed Clinical Queries

PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas

---

• Search PubMed Clinical Queries for "Melanoma" 

Results: 5 of 30159

• Disparities in diagnosis of advanced melanoma: a population-based cohort study.
  Mavor ME, Richardson H, Miao Q, Asai Y, Hanna TP.CMAJ Open. 2018 Oct-Dec; 6(4):E502-E512. Epub 2018 Oct 31.
• A meta-analysis of melanoma risk in industrial workers.
  Vujic I, Gandini S, Stanganelli I, Fierro MT, Rappersberger K, Sibilia M, Tosti G, Ferrucci PF, Caini S, De Felici MB, et al.Melanoma Res. 2018 Oct 26; . Epub 2018 Oct 26.
• Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials.
  Hinchcliff E, Hong D, Le H, Chisholm G, Iyer R, Naing A, Hwu P, Jazaeri A.Gynecol Oncol. 2018 Oct 23; . Epub 2018 Oct 23.
• Overview of model validation for survival regression model with competing risks using melanoma study data.
  Zhang Z, Cortese G, Combescure C, Marshall R, Lee M, Lim HJ, Haller B, written on behalf of AME Big-Data Clinical Trial Collaborative Group..Ann Transl Med. 2018 Aug; 6(16):325.
• Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
  Hodi FS, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Cowey CL, Lao CD, Schadendorf D, Wagstaff J, Dummer R, et al.Lancet Oncol. 2018 Oct 18; . Epub 2018 Oct 18.

See all (30159)

This column displays citations filtered to a specific clinical study category and scope. These search filters were developed by Haynes RB et al. See more filter information.

Systematic Reviews

Results: 5 of 1789

• [Contraception and cancer: CNGOF Contraception Guidelines].
  Pragout D, Laurence V, Baffet H, Raccah-Tebeka B, Rousset-Jablonski C.Gynecol Obstet Fertil Senol. 2018 Oct 29; . Epub 2018 Oct 29.
• Physical activity, cardiorespiratory fitness and risk of cutaneous malignant melanoma: Systematic review and meta-analysis.
  Behrens G, Niedermaier T, Berneburg M, Schmid D, Leitzmann MF.PLoS One. 2018; 13(10):e0206087. Epub 2018 Oct 31.
• Duration of adjuvant immunotherapy-biologic, clinical and economic considerations.
  Stav I, Gyawali B, Goldstein DA.Med Oncol. 2018 Oct 29; 35(12):160. Epub 2018 Oct 29.
• A meta-analysis of melanoma risk in industrial workers.
  Vujic I, Gandini S, Stanganelli I, Fierro MT, Rappersberger K, Sibilia M, Tosti G, Ferrucci PF, Caini S, De Felici MB, et al.Melanoma Res. 2018 Oct 26; . Epub 2018 Oct 26.
• Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
  Guo Y, Long J, Lei S.J Cell Physiol. 2018 Oct 28; . Epub 2018 Oct 28.

See all (1789)

This column displays citations for systematic reviews, meta-analyses, reviews of clinical trials, evidence-based medicine, consensus development conferences, and guidelines. See filter information or additional related sources.

Medical Genetics

Topic:AllDiagnosisDifferential DiagnosisClinical DescriptionManagementGenetic CounselingMolecular GeneticsGenetic Testing

Results: 5 of 24487

• Instability of BLOC-2 and BLOC-3 in Chinese Patients with Hermansky-Pudlak Syndrome.
  Wei A, Yuan Y, Qi Z, Liu T, Bai D, Zhang Y, Yu J, Yang L, Yang X, Li W.Pigment Cell Melanoma Res. 2018 Nov 2; . Epub 2018 Nov 2.
• A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families.
  Karimi M, von Salomé J, Aravidis C, Silander G, Askmalm MS, Henriksson I, Gebre-Medhin S, Frödin JE, Björck E, Lagerstedt-Robinson K, et al.Hered Cancer Clin Pract. 2018; 16:16. Epub 2018 Oct 23.
• CD3-bispecific antibody therapy turns solid tumors into inflammatory sites but does not install protective memory.
  Benonisson H, Altıntaş I, Sluijter M, Verploegen S, Labrijn A, Schuurhuis DH, Houtkamp MA, Verbeek JS, Schuurman J, van Hall T.Mol Cancer Ther. 2018 Oct 31; . Epub 2018 Oct 31.
• Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency.
  Watson LR, Slade CA, Ojaimi S, Barnes S, Fedele P, Smith P, Marum J, Lunke S, Stark Z, Hunter MF, et al.Allergy Asthma Clin Immunol. 2018; 14:65. Epub 2018 Oct 22.
• A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.
  Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzmán M, et al.EMBO Mol Med. 2018 Oct 30; . Epub 2018 Oct 30.

See all (24487)

This column displays citations pertaining to topics in medical genetics. See more filter information.